| |
| |
|
| Insider
Information: |
Schneid Yair |
| Relationship: |
10% Owner |
| City: |
Suffern |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
13,284,610 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,178,475 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
13,284,610 |
|
|
| Total
Value |
$2,178,475 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
ReShape Lifesciences Inc |
RSLS |
10% Owner |
2024-01-05 |
2,461,000 |
|
0 |
Premium* |
|
|
Galera Therapeutics, Inc. |
GRTX |
10% Owner |
2024-04-19 |
10,823,610 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GRTX |
Galera Therapeutics, Inc. |
10% Owner |
– – • |
2024-04-19 |
4/A |
B |
$0.19 |
$19,396 |
D/D |
100,000 |
10,823,610 |
2.37 |
- |
|
| GRTX |
Galera Therapeutics, Inc. |
10% Owner |
– – • |
2024-04-18 |
4/A |
B |
$0.19 |
$107,395 |
D/D |
547,600 |
10,723,610 |
2.45 |
- |
|
| GRTX |
Galera Therapeutics, Inc. |
10% Owner |
– – • |
2024-04-17 |
4/A |
B |
$0.19 |
$403,185 |
D/D |
1,814,657 |
10,176,010 |
2.45 |
- |
|
| GRTX |
Galera Therapeutics, Inc. |
10% Owner |
– – • |
2024-02-08 |
4 |
B |
$0.17 |
$25,650 |
D/D |
150,000 |
8,043,203 |
2.37 |
% |
|
| GRTX |
Galera Therapeutics, Inc. |
10% Owner |
– – • |
2024-02-07 |
4 |
B |
$0.17 |
$30,185 |
D/D |
175,000 |
7,893,203 |
2.37 |
% |
|
| GRTX |
Galera Therapeutics, Inc. |
10% Owner |
– – • |
2024-02-06 |
4 |
B |
$0.20 |
$5,025 |
D/D |
25,000 |
7,718,203 |
2.37 |
% |
|
| GRTX |
Galera Therapeutics, Inc. |
10% Owner |
– – • |
2024-02-05 |
4 |
B |
$0.18 |
$17,922 |
D/D |
97,402 |
7,693,203 |
2.37 |
% |
|
| GRTX |
Galera Therapeutics, Inc. |
10% Owner |
– – • |
2024-01-30 |
4 |
B |
$0.18 |
$60,635 |
D/D |
335,000 |
7,595,801 |
2.45 |
% |
|
| GRTX |
Galera Therapeutics, Inc. |
10% Owner |
– – • |
2024-01-29 |
4 |
B |
$0.18 |
$27,000 |
D/D |
150,000 |
7,260,801 |
2.37 |
% |
|
| GRTX |
Galera Therapeutics, Inc. |
10% Owner |
– – • |
2024-01-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,110,801 |
|
% |
|
| RSLS |
ReShape Lifesciences Inc |
10% Owner |
– – • |
2024-01-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,461,000 |
|
- |
|
| GRTX |
Galera Therapeutics, Inc. |
10% Owner |
– – • |
2014-04-17 |
4/A |
B |
$0.19 |
$60,449 |
D/D |
318,150 |
8,361,353 |
2.45 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
